Comparison of treatment satisfaction after switching from Semaglutide to Dulaglutide in patients with type 2 diabetes:a pilot study

Not Applicable

Completed

• Conditions: Type 2 diabetes

• Registration Number: JPRN-UMIN000047266
• Lead Sponsor: Yokosuka Kyosai Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-23
• Study Completion: 2023-03-31
• Last Update Posted: 2023-10-17

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with severe liver damage (up to 3 times normal upper limit of AST and ALT within 28 days before registration) (2) Patients with severe congestive heart failure and acute heart failure (3) Patients taking steroids (4) Patients with a history of diabetic ketoacidosis or diabetic coma during the past 6 months (5) Cancer patients currently undergoing treatment (6) Patients with severe infections, before and after surgery, with severe trauma (7) Patients who are contraindicated or allergic to the test drug (8) Pregnant, possibly pregnant, or wishing to become pregnant during the treatment period and lactating patients (9) Patients who participated in clinical trials or clinical trials of drugs or medical devices at the same time as this study or within 30 days before enrollment in this study (10) Other patients who are judged to be unsuitable as subjects by the judgment of a doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified